PCM
EOLS icon

Prelude Capital Management’s Evolus EOLS Stock Holding History

Prelude Capital Management’s Portfolio EOLS Stock Details EOLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$211K Buy
51,303
+12,000
+31% +$58.1K 0.02% 889
2025
Q4 		$261K Buy
39,303
+4,036
+11% +$27.3K 0.02% 866
2025
Q3 		$217K Buy
+35,267
New +$275K 0.02% 903
2023
Q3 		– Sell
-16,122
Closed -$117K – 1192
2023
Q2 		$117K Buy
+16,122
New +$139K 0.01% 912
2020
Q3 		– Sell
-200
Closed -$1K – 1961
2020
Q2 		$1K Hold
200
– – ﹤0.01% 1865
2020
Q1 		$1K Buy
+200
New +$1.7K ﹤0.01% 1339

Other funds holding EOLS

NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Prelude Capital Management's EOLS Position: Q1 2026 in Review

Prelude Capital Management increased its Evolus (EOLS) stake by 31% in Q1 2026, buying an estimated $58.1K and bringing the position to 51,303 shares worth $211K. The position accounts for 0.02% of the portfolio, ranked #889.

Prelude Capital Management first reported a position in EOLS in Q1 2020 and has held it in 6 quarters since. The position peaked at $261K in Q4 2025. 147 funds tracked by Wall St. Rank hold EOLS as of Q1 2026.

  • Prelude Capital Management held 51,303 shares of Evolus worth $211K as of Q1 2026.
  • Prelude Capital Management bought 12,000 Evolus shares in Q1 2026, an estimated $58.1K.
  • Evolus made up 0.02% of Prelude Capital Management's portfolio in Q1 2026, its #889 holding.
  • Prelude Capital Management first reported a position in Evolus in Q1 2020 and has held it in 6 quarters since.
  • Prelude Capital Management's Evolus position peaked at $261K in Q4 2025.
  • 147 funds tracked by Wall St. Rank held Evolus as of Q1 2026.

Based on Prelude Capital Management's 13F filing for Q1 2026, filed 15 May 2026.